Labcorp Holdings, Inc. provides laboratory services to help doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. The company is headquartered in Burlington, North Carolina and currently employs 71,000 full-time employees. The firm operates through two segments: Diagnostics Laboratories (Dx) and Biopharma Laboratory Services (BLS). The Diagnostics Laboratories segment includes routine testing and specialty/esoteric testing. Dx operates through a network of patient service centers, branches, rapid response laboratories, primary laboratories, and specialty laboratories. The BLS segment provides drug development and CDx development solutions from early-stage research to clinical development, along with support for crop protection and chemical testing, through its ED and Central Laboratory Services businesses. Its service also includes ambulatory outpatient laboratory services. The firm is focused on four primary specialty testing areas, such as oncology, women's health, autoimmune disease, and neurology.
The most recent EPS for Labcorp Holdings Inc is $4.07, beating expectations of $4.05.
How did Labcorp Holdings Inc LH's revenue perform in the last quarter?
Labcorp Holdings Inc revenue for the last quarter is $4.07
What is the revenue estimate for Labcorp Holdings Inc?
According to 17 of Wall street analyst, the revenue estimate of Labcorp Holdings Inc range from $3.7B to $3.38B
What's the earning quality score for Labcorp Holdings Inc?
Labcorp Holdings Inc has a earning quality score of A-/58.550343. The score is based on a four dimension of Profitability, Growth, Cash generation & Capital Allocation, and Leverage.
When does Labcorp Holdings Inc report earnings?
Labcorp Holdings Inc next earnings report is expected in 2026-05-18
What are Labcorp Holdings Inc's expected earnings?
Labcorp Holdings Inc expected earnings is $3.66B, according to wall-street analysts.
Did Labcorp Holdings Inc beat earnings expectations?
Labcorp Holdings Inc recent earnings of $3.51B does not beat expectations.